Coronavirus: Variant mutation lets it copy itself more efficiently
A new study from the La Jolla Institute found that the most dominant strain of the virus was a mutation of the original variant called G614, which can replicate itself more easily than the original virus.
Source: the Mail online | Health - July 3, 2020 Category: Consumer Health News Source Type: news

How a mutation on the novel coronavirus has come to dominate the globe
(La Jolla Institute for Immunology) Two variants of the novel coronavirus (SARS-CoV-2), called G614 and D614, were circulating in mid-March. A new study shows that the G version of the virus has come to dominate cases around the world. They report that this mutation does not make the virus more deadly, but it does help the virus copy itself, resulting in a higher viral load, or " titer, " in patients.
Source: EurekAlert! - Infectious and Emerging Diseases - July 2, 2020 Category: Infectious Diseases Source Type: news

Even in the worst COVID-19 cases, the body launches immune cells to fight back
A new study from researchers at La Jolla Institute for Immunology (LJI) and Erasmus University Medical Center (Erasmus MC) shows that even the sickest COVID-19 patients produce T cells that help fight the virus. The study offers further evidence that a COVID-19 vaccine will need to elicit T cells to work alongside antibodies.
Source: World Pharma News - June 29, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Propeller Health shares new data, Clinician voice assistant Suki gets a facelift and more digital health news briefs
Also: AbleTo announces new suite of CBT programs  for payers; Blockchain system tracks individuals ' COVID-19 status.
Source: mobihealthnews - June 25, 2020 Category: Information Technology Source Type: news

LJI scientists investigate a powerful protein behind antibody development
(La Jolla Institute for Immunology) Scientists at the La Jolla Institute for Immunology (LJI) have discovered a potential new way to better fight a range of infectious diseases, cancers and even autoimmune diseases.The new study, published recently in Nature Immunology, shows how a protein works as a " master regulator " in the immune system.
Source: EurekAlert! - Infectious and Emerging Diseases - June 22, 2020 Category: Infectious Diseases Source Type: news

Coronavirus: 45% of asymptomatic patients may have lung damage
A new study from Scripps Research in La Jolla, California, found that among 76 asymptomatic coronavirus patients on the Diamond Princess, 54% had lung damage indicated on CT scans.
Source: the Mail online | Health - June 16, 2020 Category: Consumer Health News Source Type: news

Fighting mosquito-borne viruses requires a precise balance of immune cells
(La Jolla Institute for Immunology) In a new study, published June 5, 2020, in the Journal of Experimental Medicine, scientists at La Jolla Institute for Immunology (LJI) shows that antibodies against JEV are 'cross-reactive' and can also recognize Zika virus. Unfortunately, these antibodies can actually make Zika cases more severe. The research, conducted in mice, is the first to show that T cells can counteract this dangerous phenomenon.
Source: EurekAlert! - Infectious and Emerging Diseases - June 5, 2020 Category: Infectious Diseases Source Type: news

How Long Does an SMAS Facelift Last?
Title: How Long Does an SMAS Facelift Last?Category: Procedures and TestsCreated: 5/21/2020 12:00:00 AMLast Editorial Review: 5/21/2020 12:00:00 AM
Source: MedicineNet Skin General - May 21, 2020 Category: Dermatology Source Type: news

Detailed analysis of immune response to SARS-CoV-2 bodes well for COVID-19 vaccine
(La Jolla Institute for Immunology) A new study documents a robust antiviral immune response to SARS-CoV-2 in a group of 20 adults who had recovered from COVID-19. The findings show that the body's immune system is able to recognize SARS-CoV-2 in many ways, dispelling fears that the virus may elude ongoing efforts to create an effective vaccine.
Source: EurekAlert! - Infectious and Emerging Diseases - May 14, 2020 Category: Infectious Diseases Source Type: news

New research gives further evidence that autoimmunity plays a role in Parkinson's disease
(La Jolla Institute for Immunology) A new study co-led by scientists at the La Jolla Institute for Immunology (LJI) adds increasing evidence that Parkinson's disease is partly an autoimmune disease. In fact, the researchers report that signs of autoimmunity can appear in Parkinson's disease patients years before their official diagnosis.
Source: EurekAlert! - Medicine and Health - April 20, 2020 Category: International Medicine & Public Health Source Type: news

Daily pep rallies help these 91-year-old twins deal with the coronavirus crisis
Residents at a La Jolla senior complex head out to their balconies every day to join employees in the courtyard below in sing-alongs and exercises.
Source: L.A. Times - Health - April 3, 2020 Category: Consumer Health News Authors: Pam Kragen Source Type: news

FaceLift: a transparent deep learning framework to beautify urban scenes - Joglekar S, Quercia D, Redi M, Aiello LM, Kauer T, Sastry N.
In the area of computer vision, deep learning techniques have recently been used to predict whether urban scenes are likely to be considered beautiful: it turns out that these techniques are able to make accurate predictions. Yet they fall short when it co...
Source: SafetyLit - April 1, 2020 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Carterra ® Inc. Selected by the La Jolla Institute of Immunology...
Funded by the Bill and Melinda Gates Foundation, CoVIC Seeks to Find Therapeutic Candidates for COVID-19 in Just Weeks(PRWeb March 31, 2020)Read the full story at https://www.prweb.com/releases/carterra_inc_selected_by_the_la_jolla_institute_of_immunology_to_provide_antibody_screening_and_characterization_for_the_coronavirus_immunotherapy_consortium_covic/prweb17016841.htm
Source: PRWeb: Medical Pharmaceuticals - March 31, 2020 Category: Pharmaceuticals Source Type: news

La Jolla Institute for Immunology to host coronavirus immunotherapy clearinghouse
(La Jolla Institute for Immunology) La Jolla Institute for Immunology (LJI) has been awarded a $1.73 million grant by the Bill& Melinda Gates Foundation to establish a Coronavirus Immunotherapy Consortium (CoVIC) as part of the foundation's global efforts to stem the tide of the current coronavirus outbreak.
Source: EurekAlert! - Infectious and Emerging Diseases - March 30, 2020 Category: Infectious Diseases Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20